Ensysce Biosciences (ENSC) Misses Q4 EPS by 75c

Ensysce Biosciences (NASDAQ: ENSC) reported Q4 EPS of ($0.75).

For earnings history and earnings-related data on Ensysce Biosciences (ENSC) click here.

You May Also Be Interested In

• BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
• Popular stocks with increasing option volume: MU SPCX INTC AMD SNDK IREN PLTR AVGO SOFI NKE MSTR NBIS ORCL
• JPMorgan Downgrades EyePoint Inc. (EYPT) to Neutral